N-(4-Bromo­phen­yl)-2-[(1-cyclo­hexyl­meth­yl-1H-1,2,4-triazol-3-yl)sulfanyl]­acetamide

The title compound, C₁₇H₂₁BrN₄OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N—H...S hydrogen bond making a five-membered ring. In the crystal, mol­ecules are connected into centrosymmetric dimers via pairs of N—H...N and weak C—H...N hydrogen bonds. The crystal structure also features C—H...O inter­actions.